UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000040383
Receipt number R000046084
Scientific Title A meta-analysis of the effect of immunonutrition on postoperative outcomes in pancreaticoduodenectomy
Date of disclosure of the study information 2020/05/12
Last modified on 2020/07/19 23:11:12

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A meta-analysis of the effect of immunonutrition on postoperative outcomes in pancreaticoduodenectomy

Acronym

A meta-analysis of the effect of immunonutrition on postoperative outcomes in pancreaticoduodenectomy

Scientific Title

A meta-analysis of the effect of immunonutrition on postoperative outcomes in pancreaticoduodenectomy

Scientific Title:Acronym

A meta-analysis of the effect of immunonutrition on postoperative outcomes in pancreaticoduodenectomy

Region

Japan


Condition

Condition

Patients who underwent pancreaticoduodenectomy

Classification by specialty

Hepato-biliary-pancreatic surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The aim of this meta-analysis was to clarify the significance of immunonutrition(IM) on short-term outcomes including pancreaticoduodenectomy(PD)-related complications in patients undergoing PD. Moreover, we explored further analysis to identify the association between IM and the incidence of each infectious complication after PD.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The aim of this meta-analysis was to clarify the significance of immunonutrition(IM) on short-term outcomes including pancreaticoduodenectomy(PD)-related complications in patients undergoing PD.

Key secondary outcomes

Moreover, we explored further analysis to identify the association between IM and the incidence of each infectious complication after PD.
Subgroup analysis including sensitivity analysis and source of funding (industry vs non-industry).


Base

Study type

Others,meta-analysis etc


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

The present study included RCT and retrospective studies in English, which compared outcomes between patients who received IM (IM group) or standard treatment (control group).

Key exclusion criteria

Records without abstracts, conference abstracts, case reports, and reviews were excluded.

Target sample size

670


Research contact person

Name of lead principal investigator

1st name Kosei
Middle name
Last name Takagi

Organization

Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences

Division name

Department of Gastroenterological Surgery

Zip code

700-8558

Address

2-5-1 Shikata-cho

TEL

+81-86-223-7151

Email

kotakagi15@gmail.com


Public contact

Name of contact person

1st name Kosei
Middle name
Last name Takagi

Organization

Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences

Division name

Department of Gastroenterological Surgery

Zip code

700-8558

Address

2-5-1 Shikata-cho

TEL

+81-86-223-7151

Homepage URL


Email

kotakagi15@gmail.com


Sponsor or person

Institute

Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences

Institute

Department

Personal name



Funding Source

Organization

NA

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

NA

Address

NA

Tel

+81-86-223-7151

Email

kotakagi15@gmail.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 05 Month 12 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

670

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2020 Year 05 Month 12 Day

Date of IRB

2020 Year 03 Month 01 Day

Anticipated trial start date

2020 Year 05 Month 12 Day

Last follow-up date

2020 Year 06 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Ethical approval: No ethical approval or informed consent statement was required for this review article.


Management information

Registered date

2020 Year 05 Month 12 Day

Last modified on

2020 Year 07 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046084


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name